Advertisement
Screener

Eledon Pharmaceuticals, Inc. (ELDN) Earnings Per Share, Basic and Diluted

Eledon Pharmaceuticals, Inc. Earnings Per Share, Basic and Diluted

Eledon Pharmaceuticals, Inc. (ELDN) reported Earnings Per Share, Basic and Diluted of -$0.69 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.

Discontinued › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-12

  • Eledon Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.69.
  • Eledon Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.66.
  • Eledon Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.50.
  • Eledon Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.57.
  • Eledon Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2021 was -$2.33.
  • Eledon Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2020 was -$15.72.
  • Eledon Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2019 was -$24.42.
  • Eledon Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2018 was -$1.56.
Period endEarnings Per Share, Basic and Diluted 3 monthEarnings Per Share, Basic and Diluted 3 month as first filedEarnings Per Share, Basic and Diluted 6 monthEarnings Per Share, Basic and Diluted 6 month as first filedEarnings Per Share, Basic and Diluted 9 monthEarnings Per Share, Basic and Diluted 9 month as first filedEarnings Per Share, Basic and Diluted 12 monthEarnings Per Share, Basic and Diluted 12 month as first filed
2022-03-31-$0.69
10-Q · filed 2022-05-12
2021-12-31-$2.33
10-K · filed 2022-03-24
2021-09-30-$0.66
10-Q · filed 2021-11-12
-$1.73
10-Q · filed 2021-11-12
2021-06-30-$0.50
10-Q · filed 2021-08-12
-$1.07
10-Q · filed 2021-08-12
2021-03-31-$0.57
10-Q · filed 2022-05-12
2020-12-31-$15.72
10-K · filed 2022-03-24
2020-09-30-$5.51
10-Q · filed 2021-11-12
-$16.81
10-Q · filed 2021-11-12
2020-06-30-$2.74
10-Q · filed 2021-08-12
-$0.15
10-Q · filed 2020-08-14
-$11.31
10-Q · filed 2021-08-12
-$0.63
10-Q · filed 2020-08-14
2020-03-31-$8.52
10-Q · filed 2021-05-14
-$0.47
10-Q · filed 2020-05-15
2019-12-31-$24.42
10-K · filed 2021-03-31
-$1.36
10-K · filed 2020-03-17
2019-09-30-$4.01
10-Q · filed 2020-11-16
-$0.22
10-Q · filed 2019-11-13
-$18.74
10-Q · filed 2020-11-16
-$1.04
10-Q · filed 2019-11-13
2019-06-30-$0.35
10-Q · filed 2020-08-14
-$0.85
10-Q · filed 2020-08-14
2019-03-31-$0.52
10-Q · filed 2020-05-15
2018-12-31-$1.56
10-K · filed 2020-03-17
2018-09-30-$0.37
10-Q · filed 2019-11-13
-$1.07
10-Q · filed 2019-11-13
2018-06-30-$0.34
10-Q · filed 2019-08-13
-$0.70
10-Q · filed 2019-08-13
2018-03-31-$0.36
10-Q · filed 2019-05-14
2017-12-31-$2.30
10-K · filed 2019-03-28
2017-09-30-$0.43
10-Q · filed 2018-11-13
-$2.25
10-Q · filed 2018-11-13
2017-06-30-$1.32
10-Q · filed 2018-08-07
-$2.51
10-Q · filed 2018-08-07
2017-03-31-$0.59
10-Q · filed 2018-05-11
-$0.17
10-Q · filed 2017-05-03
2016-12-31-$0.17
10-K · filed 2017-03-03
-$2.46
10-K · filed 2018-04-02
-$1.68
10-K · filed 2017-03-03
2016-09-30-$4.35
10-Q · filed 2017-11-08
-$0.41
10-Q · filed 2016-11-03
-$9.09
10-Q · filed 2017-11-08
-$1.51
10-Q · filed 2016-11-03
2016-06-30-$2.25
10-Q · filed 2017-08-09
-$0.60
10-Q · filed 2016-08-04
-$4.68
10-Q · filed 2017-08-09
-$1.10
10-Q · filed 2016-08-04
2016-03-31-$0.51
10-Q · filed 2017-05-03
2015-12-31-$0.49
10-K · filed 2017-03-03
-$2.01
10-K · filed 2017-03-03
2015-09-30-$0.53
10-K · filed 2017-03-03
-$1.52
10-Q · filed 2016-11-03
2015-06-30-$0.40
10-K · filed 2017-03-03
-$0.99
10-Q · filed 2016-08-04
2015-03-31-$0.59
10-K · filed 2017-03-03
2014-12-31-$0.28
10-K · filed 2016-03-10
-$1.01
derived: net income ÷ weighted average shares · filed 2017-03-03
-$2.18
derived: net income ÷ weighted average shares · filed 2017-03-03
-$3.60
10-K · filed 2017-03-03
2014-09-30-$2.71
10-K · filed 2016-03-10
-$8.57
derived: net income ÷ weighted average shares · filed 2015-11-10
-$15.19
10-Q · filed 2015-11-10
-$23.52
derived: net income ÷ weighted average shares · filed 2016-03-10
2014-06-30-$11.68
10-K · filed 2016-03-10
-$21.48
10-Q · filed 2015-08-12
-$32.69
derived: net income ÷ weighted average shares · filed 2016-03-10
-$39.53
derived: net income ÷ weighted average shares · filed 2016-03-10
2014-03-31-$9.79
10-K · filed 2016-03-10
-$21.00
derived: net income ÷ weighted average shares · filed 2016-03-10
-$27.83
derived: net income ÷ weighted average shares · filed 2016-03-10
2013-12-31-$11.23
10-K · filed 2015-03-26
-$18.04
derived: net income ÷ weighted average shares · filed 2016-03-10
-$38.02
10-K · filed 2016-03-10
2013-09-30-$6.82
10-K · filed 2015-03-26
-$26.36
10-Q · filed 2014-11-13
2013-06-30-$12.95
10-K · filed 2015-03-26
2013-03-31-$7.20
10-K · filed 2015-03-26
2012-12-31-$31.09
10-K · filed 2015-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
Foghorn Therapeutics Inc. (FHTX)United States$0.213B-4.43
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Nkarta, Inc. (NKTX)United States$0.205B-1.73
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
ORAMED PHARMACEUTICALS INC. (ORMP)$0.199B1.13
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12